Bringing drugs into the injured brain and keeping them there

Current Pharmaceutical Design

Volumn 17, Issue 26, 2011, Pages 2748-2749

  Hermann, Dirk M ^a   Patak, Pauline ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Blood brain barrier; Multidrug resistance; Neuroprotection failure

Indexed keywords

ABC TRANSPORTER; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; MULTIDRUG RESISTANCE PROTEIN 1;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN INJURY; BRAIN TISSUE; DETOXIFICATION; DRUG ACCUMULATION; DRUG TRANSPORT; EDITORIAL; HOMEOSTASIS; HUMAN; MULTIDRUG RESISTANCE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE; HUMANS;

EID: 80053505870     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Lee G, Dallas S, Hong M, Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 2001; 53: 569-96.
2. Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6: 591-602.
3. Hermann DM, Kilic E, Spudich A, Krämer SD, Wunderli-Allenspach H, Bassetti CL. Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 2006; 60: 489-98.
4. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM. Inhibition of multidrug resistance transporter- 1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 2006; 9: 487-8.
5. Hartz AM, Miller DS, Bauer B. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 2010; 77: 715-23.
6. Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL. Blood-Brain Barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration. Neurobiol Aging 2009; 30: 1818-24.
7. Mäe M, Armulik A, Betsholtz C. Getting to know the cast - cellular interactions and signaling at the neurovascular unit. Curr Pharm Des 2011; 17(26): 2750-4.
8. Ogunshola OO. In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des 2011; 17(26): 2755-61.
9. Reichel V, Mahringer A, Ott M, Reimold I, Fricker G. The ABC of the blood-brain barrier - regulation of drug efflux pumps. Curr Pharm Des 2011; 17(26): 2762-70.
10. Bartels AL. Blood-Brain Barrier P-glycoprotein function in neurodegenerative diseases. Curr Pharm Des 2011; 17(26): 2771-7.
11. Vogelgesang S, Jedlitschky G, Brenn A, Walker LC. The role of the ATP-Binding Cassette Transporters P-glycoprotein in the transport of β-amlyoid across the blood-brain barrier. Curr Pharm Des 2011; 17(26): 2778-86.
12. Patak P, Hermann DM. ATP-binding cassette transporters at the blood-brain barrier in ischaemic stroke. Curr Pharm Des 2011; 17(26): 2787-92.
13. Agarwal S, Kartz AMS, Elmquist WF, Bauer B. Breast cancer resistance protein and P-glycoprotein in brain cancer: Two gatekeepers team up. Curr Pharm Des 2011; 17(26): 2793-802.
14. Chan A, Gold R, von Ahsen N. ATP-Binding Cassette Transporters in inflammatory brain disease. Curr Pharm Des 2011; 17(26): 2803-7.
15. Löscher W, Luna-Tortós C, Römermann K, Fedrowitz M. Do ATP-Binding Cassette Transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected. Curr Pharm Des 2011; 17(26): 2808-28.
16. Tournier N, Declèves X, Saubaméa B, Scherrmann J-M, Cisternino S. Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology. Curr Pharm Des 2011; 17(26): 2829-42.
17. Rosenhagen MC, Uhr M. The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases. Curr Pharm Des 2011; 17(26): 2843-51.
18. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.
19. ElAli A, and Hermann DM (2010) Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain. Sci Signal 3: ra72.
20. Kooij G, Mizee MR, van Horssen J, Reijerkerk A, Witte ME, Drexhage JA, van der Pol SM, van Het Hof B, Scheffer G, Scheper R, Dijkstra CD, van der Valk P, de Vries HE. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain 2011; 134: 555-570.